New Drugs
This group will cover new drugs under development and recently FDA/EMEA approved drugs. It will cover pharmaceutical and biotechnology R&D, Regulatory oversight, GCP, Informed Consent, Clinical trials, ADR, safety, efficacy, compliance and publications of failed trials.
Open invitation to all interested members
-
Krishan Maggon PhDEditor
Pharma Biotech R&D Advisor
-
Founder and Chief Apostle, Breakthrough Innovation, InnoThink Center for Research in Biomedical Innovation
-
PhD in Organic chemistry
-
Daniel H Jacobs MDEditor
Assoc Prof UCF Coll Med
No documents have been uploaded.